FDA — authorised 28 December 1995
- Application: NDA020491
- Marketing authorisation holder: PFIZER
- Local brand name: CORVERT
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Corvert on 28 December 1995
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 28 December 1995; FDA authorised it on 1 April 2024.
PFIZER holds the US marketing authorisation.